SG Corporation

Republic of Korea

Back to Profile

1-2 of 2 for SG Corporation Sort by
Query
Aggregations
Jurisdiction
        United States 1
        World 1
IPC Class
A61K 36/754 - Evodia 2
A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives 1
A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives 1
A61K 31/407 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine 1
A61K 31/4375 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine 1
See more
Found results for  patents

1.

Composition for preventing or treating diseases caused by caffeine abuse including Evodia officinalis extract or evodiamine as active ingredient

      
Application Number 16466484
Grant Number 11219658
Status In Force
Filing Date 2017-12-01
First Publication Date 2019-10-17
Grant Date 2022-01-11
Owner
  • SG CORPORATION (Republic of Korea)
  • Research and Business Foundation Sungkyunkwan University (Republic of Korea)
Inventor Jang, Choon Gon

Abstract

Evodia officinalis extract or evodiamine.

IPC Classes  ?

  • A61K 36/00 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
  • A61K 36/754 - Evodia
  • A61P 25/30 - Drugs for disorders of the nervous system for treating abuse or dependence
  • A61K 31/4375 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring hetero atom, e.g. quinolizines, naphthyridines, berberine, vincamine

2.

COMPOSITION FOR PREVENTING OR TREATING DISEASES CAUSED BY CAFFEINE ADDICTION INCLUDING EUODIA EXTRACT OR EVODIAMINE AS ACTIVE INGREDIENT

      
Application Number KR2017014021
Publication Number 2018/105960
Status In Force
Filing Date 2017-12-01
Publication Date 2018-06-14
Owner
  • SG CORPORATION (Republic of Korea)
  • RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY (Republic of Korea)
Inventor Jang, Choon Gon

Abstract

The present invention relates to a composition which is for preventing or treating caffeine addiction and includes evodiamine or euodia extract. More specifically, the present invention relates to a pharmaceutical composition which has an effect of preventing or alleviating somnipathy and central nervous system excitation caused by caffeine. In addition, the present invention relates to a caffeine addiction treatment method and a health functional food composition including euodia extract or evodiamine.

IPC Classes  ?

  • A61K 31/519 - PyrimidinesHydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
  • A61K 31/407 - Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine
  • A61K 36/754 - Evodia
  • A23L 33/10 - Modifying nutritive qualities of foodsDietetic productsPreparation or treatment thereof using additives
  • A23L 33/105 - Plant extracts, their artificial duplicates or their derivatives